AIGH Capital Management LLC - Q3 2022 holdings

$322 Million is the total value of AIGH Capital Management LLC's 98 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 150.0% .

 Value Shares↓ Weighting
NewADTRAN HOLDINGS INC$22,733,0001,161,019
+100.0%
7.06%
MTRN BuyMATERION CORP$19,295,000
+44.4%
241,189
+33.1%
6.00%
+70.6%
AVNW BuyAVIAT NETWORKS INC$14,674,000
+43.7%
535,918
+31.4%
4.56%
+69.6%
TELA BuyTELA BIO INC$13,033,000
+504.5%
1,529,669
+399.1%
4.05%
+614.3%
INDI NewINDIE SEMICONDUCTOR INC$10,634,0001,452,766
+100.0%
3.30%
ANIP BuyANI PHARMACEUTICALS INC$10,105,000
+39.3%
314,406
+28.6%
3.14%
+64.5%
PRTK BuyPARATEK PHARMACEUTICALS INC$9,990,000
+52.8%
3,887,172
+14.8%
3.10%
+80.5%
ICAD BuyICAD INC$3,686,000
-32.3%
1,755,634
+29.0%
1.15%
-20.0%
MDNA BuyMEDICENNA THERAPEUTICS CORP$3,193,000
+20.6%
3,850,154
+69.4%
0.99%
+42.5%
APEN NewAPOLLO ENDOSURGERY INC$2,802,000508,536
+100.0%
0.87%
EOLS BuyEVOLUS INC$1,610,000
-19.6%
200,000
+15.9%
0.50%
-5.1%
NewCAPSTONE GREEN ENERGY CORP$1,593,000900,000
+100.0%
0.50%
OSMT BuyRVL PHARMACEUTICALS PLC$1,553,000
+1238.8%
739,531
+770.1%
0.48%
+1458.1%
BuyCONTEXT THERAPEUTICS INC$1,434,000
+20.7%
1,291,771
+8.4%
0.45%
+42.5%
ADVM NewADVERUM BIOTECHNOLOGIES INC$1,140,0001,200,000
+100.0%
0.35%
NewSOLENO THERAPEUTICS INC$708,000424,089
+100.0%
0.22%
NewCELLECTAR BIOSCIENCES INC$586,000174,422
+100.0%
0.18%
NewABEONA THERAPEUTICS INC$428,000140,644
+100.0%
0.13%
CMBM NewCAMBIUM NETWORKS CORP$325,00019,182
+100.0%
0.10%
ATNX NewATHENEX INC$269,0001,000,134
+100.0%
0.08%
NLSPW NewNLS PHARMACEUTICS LTD*w exp 09/25/202$158,000633,361
+100.0%
0.05%
NewSAVERONE 2014 LTD*w exp 06/02/202$128,000428,330
+100.0%
0.04%
CYTHW NewCYCLO THERAPEUTICS INC*w exp 11/14/202$77,000219,795
+100.0%
0.02%
NewSAVERONE 2014 LTDcall$42,000141,364
+100.0%
0.01%
NewPARABELLUM ACQUISITION CORP*w exp 99/99/999$8,000450,214
+100.0%
0.00%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SCPHARMACEUTICALS INC15Q2 20248.5%
IDEAL PWR INC14Q2 20242.5%
FRANKLIN WIRELESS CORP14Q2 20242.9%
LIGHTPATH TECHNOLOGIES INC13Q2 20243.0%
MYOMO INC13Q2 20245.3%
AVIAT NETWORKS INC12Q3 20236.8%
THERATECHNOLOGIES INC11Q2 20232.9%
MEDICENNA THERAPEUTICS CORP11Q3 20231.1%
PARATEK PHARMACEUTICALS INC10Q1 20233.2%
COGNITION THERAPEUTICS INC10Q2 20241.5%

View AIGH Capital Management LLC's complete holdings history.

Latest significant ownerships (13-D/G)
AIGH Capital Management LLC Q3 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Bridgeline Digital, Inc.May 21, 2021627,4199.7%

View AIGH Capital Management LLC's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-09-06
13F-HR2024-08-07
13F-HR2024-05-14
13F-HR2024-02-12
13F-HR2023-11-13
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-15
13F-HR2022-11-14
13F-HR2022-08-12

View AIGH Capital Management LLC's complete filings history.

Compare quarters

Export AIGH Capital Management LLC's holdings